{"metadata": {"organization_names": [], "person_names_verified": [], "organization_names_verified": ["shire pharmaceuticals group", "shire biopharmaceuticals holdings"], "vars": {}, "entities_rejected": [], "person_names": [], "agreement_id": "8275535dd5fb8b1de815bc9e5e66f204f2259d7c0bc338288916220db11352ef", "topics": [], "terms": ["**\"Cause\"**", "**(JZF)**", "**(MV \u2013 EP) X C**", "**APPENDIX A - AWARDS TO CANADIAN PARTICIPANTS**", "**Adjusted ROIC**", "**Adjustment for dividends**", "**Adjustment of Awards**", "**Adjustment of Performance Targets**", "**Adjustment of SAR Awards**", "**Administration**", "**CHANGE IN CONTROL AND LIQUIDATION**", "**CONTENTS**", "**Cessation of Employment \u2013 Unvested PSA Awards**", "**Cessation of employment - Vested SAR Awards**", "**Cessation of employment - general**", "**Cessation of employment \u2013 Unvested SAR Awards**", "**Construction**", "**Costs and expenses**", "**Death of a Participant**", "**Deed of grant for PSA Awards**", "**Deed of grant for SAR Awards**", "**Definitions**", "**Disputes**", "**EBITDA growth (CAGR 2009-2012)**", "**EC1Y 8YY**", "**ELIGIBILITY**", "**EXERCISE OF SAR AWARDS AND RELEASE OF SHARES**", "**Exchange of PSA Awards**", "**Exchange of SAR Awards**", "**Exercise of SAR Awards**", "**GENERAL**", "**GRANT OF PSA AWARDS**", "**GRANT OF SAR AWARDS**", "**General Offer**", "**General**", "**Governing law**", "**Grant of PSA Awards**", "**Grant of SAR Awards**", "**INDIVIDUAL LIMIT**", "**INTERPRETATION AND CONSTRUCTION**", "**Increase bp p.a.**", "**Issue or Transfer of Shares on exercise of a Vested SAR Award**", "**Issue or Transfer of Shares**", "**LAPSE OF PSA AWARDS**", "**LAPSE OF SAR AWARDS**", "**LOSS OF OFFICE**", "**Lapsing of PSA Awards**", "**Lapsing of SAR Awards**", "**Life of Plan**", "**Market Value\u201d**", "**Meaning of ceasing to be employed within the Group**", "**Meaning of terms used in Rule 14**", "**NON-TRANSFERABILITY OF PSA AWARDS**", "**NON-TRANSFERABILITY OF SAR AWARDS**", "**NOTICES**", "**Notification of adjustment**", "**Notification to Participant**", "**One Bunhill Row**", "**Operation of Part A of the Plan**", "**Operation of Part B of the Plan**", "**Overriding Provision**", "**PART A \u2013 STOCK-SETTLED STOCK APPRECIATION RIGHTS AWARDS**", "**PART B \u2013 PERFORMANCE SHARE AWARDS**", "**PLAN LIMITS**", "**PLAN SUMMARY**", "**PROCEDURE ON VESTING**", "**Page**", "**Part 18 Companies (Jersey) Law 1991**", "**Power of amendment**", "**Provision of Shares**", "**RESTRICTIONS UPON VESTING**", "**SCHEDULE - - PERFORMANCE TARGET**", "**SLAUGHTER AND MAY**", "**Share Dealing Code**", "**Shares or ADSs comprised in a PSA Award**", "**Shares or ADSs comprised in a SAR Award**", "**Sub plans**", "**THE RULES OF THE SHIRE PORTFOLIO SHARE PLAN**", "**THE SHIRE PORTFOLIO SHARE PLAN**", "**Termination**", "**The Shire Portfolio Share Plan**", "**To Eligible Employees and Participants**", "**To the Company**", "**To the Trustee**", "**VARIATION OF CAPITAL**", "**VESTING OF PSA AWARDS**", "**VESTING OF SAR AWARDS**", "**Vesting of Awards**", "**Vesting of PSA Awards**", "**Vesting of SAR Awards**", "**Winding-up**", "**Withholding obligations**", "**[[Address 1: Address]]*", "**allocate**", "**appropriate period**", "**award**", "**discretionary scheme**", "**employee share scheme**", "**equity share capital**", "**new award**", "**old award**", "**pay**", "**relevant period**", "**\u201cADS\u201d**", "**\u201cAssociated Company\u201d**", "**\u201cAuditors\u201d**", "**\u201cBoard\u201d**", "**\u201cCause\u201d**", "**\u201cCommittee\u201d**", "**\u201cCompany\u201d**", "**\u201cConditions\u201d**", "**\u201cControl\u201d**", "**\u201cDate of Grant\u201d**", "**\u201cDealing Day\u201d**", "**\u201cEligible Employee\u201d**", "**\u201cExercise Period\u201d**", "**\u201cExercise Price\u201d**", "**\u201cFinancial Year\u201d**", "**\u201cGrant Period\u201d**", "**\u201cGrantor\u201d**", "**\u201cGroup\u201d**", "**\u201cPSA Award\u201d**", "**\u201cPart A\u201d**", "**\u201cPart B\u201d**", "**\u201cParticipant\u201d**", "**\u201cPerformance Period\u201d**", "**\u201cPerformance Target\u201d**", "**\u201cPermitted Reason\u201d**", "**\u201cPlan\u201d**", "**\u201cRelevant Period**\u201d", "**\u201cRetirement\u201d**", "**\u201cRules\u201d**", "**\u201cSAR Award\u201d**", "**\u201cService Factor\u201d**", "**\u201cShares\u201d**", "**\u201cSubsidiary\u201d**", "**\u201cTrustee\u201d**", "**\u201cTrust\u201d**", "**\u201cUK Listing Authority\u201d**", "**\u201cUnvested PSA Award\u201d**", "**\u201cUnvested SAR Award\u201d**", "**\u201cVested PSA Award\u201d**", "**\u201cVested SAR Award\u201d**", "**\u201cVesting Date\u201d**", "**\u201c[[Address 2: Address]]\u201d**", "\u201c**Canadian Participant**\u201d", "\u201c**Company**\u201d", "\u201c**Conditions**\u201d", "\u201c**Market Value\u201d**", "\u201c**Performance Target**\u201d", "\u201c**ROIC**\u201d", "\u201c**member of the Group**\u201d"]}}